IL-34 and Immune Checkpoint Inhibitors Resistant through Macrophages: Pan-Cancer Overview

Mohammed Safi; Al Shaebi Fadhl; Yousif A. Algabri; Caiqing Zhang

doi:10.2147/JIR.S397749

IL-34 and Immune Checkpoint Inhibitors Resistant through Macrophages: Pan-Cancer Overview

Mohammed Safi, Al Shaebi Fadhl, Yousif A. Algabri, Caiqing Zhang

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1209-1212
Number of pages	4
Journal	Journal of Inflammation Research
Volume	16
DOIs	https://doi.org/10.2147/JIR.S397749
State	Published - 2023
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.2147/JIR.S397749

Cite this

@article{343d0cd4845a4379b905db9a71264bef,

title = "IL-34 and Immune Checkpoint Inhibitors Resistant through Macrophages: Pan-Cancer Overview",

author = "Mohammed Safi and Fadhl, \{Al Shaebi\} and Algabri, \{Yousif A.\} and Caiqing Zhang",

note = "Funding Information: This research was funded by the National Natural Science Foundation of China, Grant/Award Number: 62271292.",

year = "2023",

doi = "10.2147/JIR.S397749",

language = "English (US)",

volume = "16",

pages = "1209--1212",

journal = "Journal of Inflammation Research",

issn = "1178-7031",

publisher = "Dove Medical Press Ltd",

}

TY - JOUR

T1 - IL-34 and Immune Checkpoint Inhibitors Resistant through Macrophages

T2 - Pan-Cancer Overview

AU - Safi, Mohammed

AU - Fadhl, Al Shaebi

AU - Algabri, Yousif A.

AU - Zhang, Caiqing

N1 - Funding Information: This research was funded by the National Natural Science Foundation of China, Grant/Award Number: 62271292.

PY - 2023

Y1 - 2023

UR - https://www.scopus.com/pages/publications/85151759001

UR - https://www.scopus.com/inward/citedby.url?scp=85151759001&partnerID=8YFLogxK

U2 - 10.2147/JIR.S397749

DO - 10.2147/JIR.S397749

M3 - Letter

C2 - 36974205

AN - SCOPUS:85151759001

SN - 1178-7031

VL - 16

SP - 1209

EP - 1212

JO - Journal of Inflammation Research

JF - Journal of Inflammation Research

ER -

IL-34 and Immune Checkpoint Inhibitors Resistant through Macrophages: Pan-Cancer Overview

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this